1Gupta SK, Southam M, Gale R, et al. System functionality and physicochemical model of fentanyl transdermal system. J Pain Symptom Manage, 1992, 7:17～26.
2Lehmann KA, Zech D. Transdermal fentanyl: clinical pharmacology. J Pain Symptom Manage,1992,7:8～16.
3Roy SD, Hou SY, Witham SL, et al. Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver skin and hairless mouse skin. J Pharm Sci,1994,83:1723～1728.
4Gourlay GK, Kowalski SR, Plummer JL, et al. The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects. Pain,1989,37:193～202.
5Gourlay GK, Kowalski SR, Plummer JL, et al. The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems. Pain,1990,40:21～28.
6Varvel JR, Shafer SL, Hwang SS, et al. Absorption characteristics of transdermally administered fentanyl. Anesthesiology,1989,70:928～936.
7Grond S, Radbruch L, Lehmann KA. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharcokinet,2000,38:59～89.
8Southam MA. Transdermal fentanyl therapy: system design, pharmacokinetics and efficacy. Anticancer Drugs,1995,6:29～34.
9Durcan TG, Sockalingham I, Hanna MH, et al. Pharmacokinetic study of repeated 72 hour applications of TTS-fentanyl. Br J Anaesth,1995,74:139.
10Broome IJ, Wright BM, Bower S, et al. Postoperative analgesia with transdermal fentanyl following lower abdominal surgery. Anaesthesia,1995,50:300～303.
